Filing Details
- Accession Number:
- 0000899243-20-013017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-13 18:07:47
- Reporting Period:
- 2020-05-12
- Accepted Time:
- 2020-05-13 18:07:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1629137 | Global Blood Therapeutics Inc. | GBT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190270 | L Mark Perry | C/O Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-12 | 15,000 | $20.00 | 41,428 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-12 | 8,600 | $20.00 | 50,028 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-12 | 15,000 | $18.85 | 65,028 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-12 | 15,000 | $28.45 | 80,028 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-12 | 2,633 | $74.01 | 77,395 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 1,350 | $75.43 | 76,045 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 600 | $76.28 | 75,445 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 13,024 | $77.71 | 62,421 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 34,698 | $78.65 | 27,723 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 1,295 | $79.17 | 26,428 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-05-12 | 15,000 | $0.00 | 15,000 | $20.00 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-05-12 | 8,600 | $0.00 | 8,600 | $20.00 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-05-12 | 15,000 | $0.00 | 15,000 | $18.85 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-05-12 | 15,000 | $0.00 | 15,000 | $28.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-08-10 | No | 4 | M | Direct | |
| 0 | 2025-08-10 | No | 4 | M | Direct | |
| 0 | 2026-06-15 | No | 4 | M | Direct | |
| 0 | 2027-06-19 | No | 4 | M | Direct |
Footnotes
- Represents weighted average sales price. The shares were sold at prices ranging from $73.90 to $74.11. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents weighted average sales price. The shares were sold at prices ranging from $75.13 to $75.88. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents weighted average sales price. The shares were sold at prices ranging from $76.15 to $76.44. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents weighted average sales price. The shares were sold at prices ranging from $77.16 to $78.01. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents weighted average sales price. The shares were sold at prices ranging from $78.16 to $79.1450. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents weighted average sales price. The shares were sold at prices ranging from $79.16 to $79.18. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The shares subject to the option are fully vested.
Billionaire Hedge Funds
